Analyst Price Target is $50.29
▲ +165.64% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for BioXcel Therapeutics in the last 3 months. The average price target is $50.29, with a high forecast of $76.00 and a low forecast of $22.00. The average price target represents a 165.64% upside from the last price of $18.93.
Current Consensus is
The current consensus among 7 polled investment analysts is to buy stock in BioXcel Therapeutics. This Buy consensus rating has held steady for over two years.